메뉴 건너뛰기




Volumn 44, Issue 2, 1997, Pages 206-208

The effect of age on plasma MEGX concentrations

Author keywords

Ageing; Monoethylglycinexylidide (MEGX)

Indexed keywords

DEETHYLLIDOCAINE; LIDOCAINE;

EID: 0030742494     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2125.1997.00651.x     Document Type: Article
Times cited : (16)

References (11)
  • 1
    • 0024408814 scopus 로고
    • Lidocaine metabolism in human liver microsomes by cytochrome P450 III A4
    • Bargetzi MJ, Aoyama T, Gonzales FJ, Meyer UA. Lidocaine metabolism in human liver microsomes by cytochrome P450 III A4. Clin Pharmacol Ther 1989; 46: 521-527.
    • (1989) Clin Pharmacol Ther , vol.46 , pp. 521-527
    • Bargetzi, M.J.1    Aoyama, T.2    Gonzales, F.J.3    Meyer, U.A.4
  • 3
    • 0029330191 scopus 로고
    • Update on the use of metabolic probes to quantify liver function: Caffeine versus lidocaine
    • Ziebell J, Shaw-Stiffel T. Update on the use of metabolic probes to quantify liver function: caffeine versus lidocaine. Dig Dis 1995; 13: 239-250.
    • (1995) Dig Dis , vol.13 , pp. 239-250
    • Ziebell, J.1    Shaw-Stiffel, T.2
  • 4
    • 8544254530 scopus 로고
    • The effect of age and sex on hepatic lidocaine metabolism
    • Kensing KP, Lasater JM, Le Sage GD. The effect of age and sex on hepatic lidocaine metabolism. Hepatology 1991; 14: 230A.
    • (1991) Hepatology , vol.14
    • Kensing, K.P.1    Lasater, J.M.2    Le Sage, G.D.3
  • 6
    • 0029912796 scopus 로고    scopus 로고
    • A reassessment of the optimal sampling time for the MEGX liver function test
    • Orlando R, Floreani M, Palatini P. A reassessment of the optimal sampling time for the MEGX liver function test. Clin Drug Invest 1996; 12: 181-187.
    • (1996) Clin Drug Invest , vol.12 , pp. 181-187
    • Orlando, R.1    Floreani, M.2    Palatini, P.3
  • 8
    • 0029839832 scopus 로고    scopus 로고
    • Use of hepatic lidocaine metabolism to monitor patients with chronic liver disease
    • Shiffman ML, Luketic VA, Sanyal AJ, Thompson EB. Use of hepatic lidocaine metabolism to monitor patients with chronic liver disease. Ther Drug Monit 1996; 18: 372-377.
    • (1996) Ther Drug Monit , vol.18 , pp. 372-377
    • Shiffman, M.L.1    Luketic, V.A.2    Sanyal, A.J.3    Thompson, E.B.4
  • 9
    • 0024447750 scopus 로고
    • Clinical pharmacokinetic considerations in the elderly. An update
    • Dawling S, Crome P. Clinical pharmacokinetic considerations in the elderly. An update. Clin Pharmacokinet 1989; 17: 236-263.
    • (1989) Clin Pharmacokinet , vol.17 , pp. 236-263
    • Dawling, S.1    Crome, P.2
  • 11
    • 0028228492 scopus 로고
    • Influence of gender on the monoethylglycinexylidide test in normal subjects and liver donors
    • Oellerich M, Schütz E, Polzien F, et al. Influence of gender on the monoethylglycinexylidide test in normal subjects and liver donors. Ther Drug Monit 1994; 16: 225-231.
    • (1994) Ther Drug Monit , vol.16 , pp. 225-231
    • Oellerich, M.1    Schütz, E.2    Polzien, F.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.